Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
Clinical trial NCT06570291 · RECRUITING
Trial details
- NCT number
- NCT06570291
- Sponsor
- Wuxi Cellular Biopharmaceutical Group Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-12-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.